BCM
NEO icon

Blume Capital Management’s NeoGenomics NEO Stock Holding History

Blume Capital Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,550
Closed -$23.6K – 326
2022
Q4 		$23.6K Sell
2,550
-500
-16% -$4.66K 0.01% 205
2022
Q3 		$26K Sell
3,050
-600
-16% -$5.96K 0.01% 187
2022
Q2 		$30K Hold
3,650
– – 0.01% 185
2022
Q1 		$44K Sell
3,650
-180
-5% -$3.79K 0.01% 166
2021
Q4 		$131K Buy
3,830
+1,800
+89% +$70.5K 0.04% 123
2021
Q3 		$98K Hold
2,030
– – 0.04% 131
2021
Q2 		$92K Buy
+2,030
New +$89.9K 0.03% 132

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Blume Capital Management's NEO Position: Q1 2023 in Review

Blume Capital Management sold out of NeoGenomics (NEO) in Q1 2023, closing a stake of 2,550 shares — an estimated $23.6K sold.

Blume Capital Management first reported a position in NEO in Q2 2021 and held it in 7 quarters. The position peaked at $131K in Q4 2021. 256 funds tracked by Wall St. Rank hold NEO as of Q1 2023.

  • Blume Capital Management reported no remaining NeoGenomics position as of Q1 2023 after selling out during the quarter.
  • Blume Capital Management sold 2,550 NeoGenomics shares in Q1 2023, an estimated $23.6K.
  • Blume Capital Management first reported a position in NeoGenomics in Q2 2021 and held it in 7 quarters.
  • Blume Capital Management's NeoGenomics position peaked at $131K in Q4 2021.
  • 256 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2023.

Based on Blume Capital Management's 13F filing for Q1 2023, filed 8 May 2023.